Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
Derm-Infectious Disease
What are your recommendations for administering the monkeypox vaccine to patients on biologics?
Patient is on IL-23 inhibitor for psoriasis
Related Questions
What treatment modalities have you had success with for treating extensive molluscum in the pediatric population?
What treatment modalities have you had success with for treating recalcitrant warts?
What modalities have you had success with in treating genital warts?
What is your approach for managing molluscum in adults?
Is there a role for empiric scabies treatment in itchy patients without clear clinical signs of scabies?
What is your approach to deciding when to stop therapy for cutaneous Mycobacterium chelonae infections?
What treatments do you recommend for patients with pityrosporum folliculitis?
How would you manage a patient with progressive/refractory molluscum contagiosum who is well controlled on methotrexate for seropositive rheumatoid arthritis?
For how long would you treat Klebsiella aerogenes folliculitis of the face manifesting as a cystic lesion?
How do you approach treatment change in patients with psoriasis who have been stable on an IL-17 or IL-23 agent but then begin to have breakthrough skin disease?
